Viewing Study NCT03258320

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2026-01-29 @ 7:38 AM
Study NCT ID: NCT03258320
Status: RECRUITING
Last Update Posted: 2024-04-17
First Post: 2017-08-20
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients Without Metastasis
Sponsor: Shanghai Jiao Tong University School of Medicine
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer Patients View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cabazitaxel View
None Docetaxel View
None Mitoxantrone View
None Satraplatin View
None Surgery View
None Prostate Cancer View
None Localized View
None High Risk View